Johnson & Johnson Services Inc Executive and Leadership Team

Joaquin Duato, the Chief Executive Officer at Johnson & Johnson Services Inc, directs the company's overarching strategy and global operations. This leadership role involves guiding the development and delivery of innovative pharmaceuticals and advanced medical technologies. Duato ensures alignment across all business segments, focusing on areas such as oncology, immunology, neuroscience, and cardiovascular care. Overseeing the company's commitment to advancing healthcare worldwide, Duato drives initiatives that enhance patient outcomes and support healthcare providers. The Chief Executive Officer's vision shapes the company's market impact and its dedication to improving global health through scientific innovation and patient-centric solutions. Joaquin Duato's leadership ensures Johnson & Johnson Services Inc maintains its position as a leader in the healthcare industry, fostering a culture of research and development to address unmet medical needs.

Ketaki Mahajan, the Chief Financial Officer & VP, Corporate Operations, IT & Global Finance Talent Development at Johnson & Johnson Services Inc, manages the company's financial health and operational efficiency. This multifaceted role encompasses overseeing financial planning, reporting, and strategic resource allocation across the organization. Mahajan directs corporate operations and IT functions, ensuring robust technological infrastructure supports business objectives. Furthermore, the executive drives the development of global finance talent, cultivating a skilled workforce for future leadership. Ketaki Mahajan's oversight of these critical areas ensures seamless integration between financial strategy and operational execution, supporting the company's mission to deliver innovative healthcare solutions. The Chief Financial Officer & VP's responsibilities extend to optimizing financial performance and driving growth in pharmaceuticals and medical technologies.

Stephen Tremel, the Business Operations Chief Financial Officer & Vice President at Johnson & Johnson Services Inc, provides critical financial oversight for business operations. This executive role focuses on optimizing financial performance and resource management within key operational segments. Tremel's responsibilities include developing financial strategies that support the company's extensive portfolio of pharmaceuticals and medical technologies. The Business Operations Chief Financial Officer & Vice President ensures financial discipline and drives efficiency across various departments. Stephen Tremel's expertise contributes to the company's ability to deliver innovative medicines and surgical products by managing financial resources effectively. This leadership position is vital for maintaining the financial integrity and operational success of Johnson & Johnson Services Inc's global endeavors.

Andre Muller, the Executive Vice President & Chief Financial Officer at Johnson & Johnson Services Inc, holds a pivotal position in directing the company's financial strategy and performance. This executive leadership role involves comprehensive oversight of all financial activities, including capital management, investment strategies, and financial reporting. Muller ensures robust financial controls and compliance across global operations, supporting the development of pharmaceuticals and medical technologies. The Executive Vice President & Chief Financial Officer plays a key part in driving sustainable growth and profitability. Andre Muller's strategic financial guidance is essential for Johnson & Johnson Services Inc's mission to provide innovative healthcare solutions to patients and providers worldwide. This role underpins the company's ability to invest in research and development.

Salvatore Giovine, the Chief Financial Officer & Vice President, Finance, Innovative Medicine (North America) at Johnson & Johnson Services Inc, leads financial operations for the Innovative Medicine segment within North America. This executive role focuses on strategic financial planning, budgeting, and analysis to support the region's pharmaceutical business. Giovine ensures financial resources are effectively allocated to drive the development and commercialization of new medicines. The Chief Financial Officer & Vice President's responsibilities include optimizing financial performance and identifying growth opportunities within the North American market. Salvatore Giovine's financial acumen is critical for advancing Johnson & Johnson Services Inc's commitment to providing innovative treatments for oncology, immunology, and neuroscience. This leadership ensures financial alignment with strategic goals in a key market.

Daniel Foo, the Director, Finance (Surgery) & Chief Financial Officer, Medtech Anz at Johnson & Johnson Services Inc, provides dedicated financial leadership for the Medtech segment in the ANZ region, with a specific focus on surgical products. This executive role involves managing financial planning, analysis, and reporting to support regional business objectives. Foo ensures financial strategies align with the company's goals for developing and distributing advanced surgical technologies. The Director, Finance (Surgery) & Chief Financial Officer's responsibilities include driving financial performance and identifying opportunities for growth within the ANZ market. Daniel Foo's financial expertise is crucial for Johnson & Johnson Services Inc's commitment to advancing surgical care and delivering innovative medical devices. This leadership ensures financial health in a key geographic area.

Lauren Johnson, the Chief Financial Officer, External Innovation Finance at Johnson & Johnson Services Inc, directs financial strategy and operations for the company's external innovation initiatives. This executive role focuses on managing the financial aspects of partnerships, acquisitions, and investments in emerging technologies and companies. Johnson ensures that financial resources are strategically deployed to foster groundbreaking advancements in pharmaceuticals and medical devices. The Chief Financial Officer, External Innovation Finance plays a critical part in evaluating and integrating external opportunities that align with Johnson & Johnson Services Inc's long-term vision. Lauren Johnson's financial expertise is vital for driving innovation and securing the company's future growth in healthcare. This position supports the exploration of new scientific frontiers.

Diandra Hayban, the Global Director, Procurement & Chief Revenue Officer, Functional & Clinical Services at Johnson & Johnson Services Inc, directs strategic sourcing and revenue generation for critical support functions. This executive role involves optimizing procurement processes to ensure cost-effectiveness and supply chain reliability for pharmaceuticals and medical technologies. Hayban also drives revenue growth within functional and clinical services, enhancing the company's service offerings. The Global Director, Procurement & Chief Revenue Officer's oversight ensures efficient resource utilization and maximizes value creation. Diandra Hayban's leadership in procurement and revenue generation is integral to Johnson & Johnson Services Inc's operational excellence and its ability to deliver innovative healthcare solutions globally. This dual focus supports both cost management and business expansion.

Nina Martinez, the Category Director, Innovative Medicine Procurement, Functional Chief Revenue Officer and Clinical Services at Johnson & Johnson Services Inc, leads strategic procurement for innovative medicines and drives revenue within functional and clinical services. This executive position involves optimizing the sourcing of critical components and services essential for pharmaceutical development and delivery. Martinez also focuses on enhancing revenue streams from the company's support functions and clinical offerings. The Category Director, Innovative Medicine Procurement, Functional Chief Revenue Officer and Clinical Services ensures efficient supply chains and identifies new avenues for business growth. Nina Martinez's leadership contributes significantly to Johnson & Johnson Services Inc's ability to bring life-changing medicines to market and expand its service capabilities. This role bridges procurement efficiency with revenue generation.

Joy Marini, the Global Director, Women's Health, Office of the Chief Medical Officer at Johnson & Johnson Services Inc, leads strategic initiatives focused on women's health within the Chief Medical Officer's organization. This executive role involves overseeing programs and research aimed at addressing critical health needs specific to women. Marini ensures that the company's efforts in pharmaceuticals and medical technologies align with advancing women's healthcare outcomes globally. The Global Director, Women's Health's responsibilities include driving innovation and collaboration to improve patient care and access to treatments. Joy Marini's leadership is instrumental in reinforcing Johnson & Johnson Services Inc's commitment to developing specialized healthcare solutions and positively impacting the lives of women worldwide. This focus area is key to the company's broad healthcare mission.